Yonhap Infomax NewsJan 28
Celltrion reported that its infliximab SC drug Zymfentra achieved record-high weekly prescriptions in the US, up 27% month-on-month and 352% year-on-year, driven by intensified marketing efforts.
#YonhapInfomax #Celltrion #Zymfentra #PrescriptionVolume #USMarket #MarketingStrategy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102451
Celltrion Says Zymfentra Sets All-Time Weekly Prescription Record in US

Celltrion reported that its infliximab SC drug Zymfentra achieved record-high weekly prescriptions in the US, up 27% month-on-month and 352% year-on-year, driven by intensified marketing efforts.

Yonhap Infomax